|
|
||||||||
Original Research Communications |
1 From the Equipe Associée Lipides et Croissance, Université de Tours, Tours and Institut National de la Recherche Agronomique, Jouy-en-Josas; Centre de Recherche Clinique, Université de Tours; and Direction Scientifique, Groupe Danone, Paris.
Background: Factors other than dietary fatty acids could be involved in the variability observed in blood docosahexaenoate (22:6n-3) and arachidonate (20:4n-6) status in formula-fed infants.
Objective: We considered the 22:6n-3 and 20:4n-6 status at birth to be one of these factors and studied its influence on postnatal changes in term infants fed 4 different diets.
Design: The blood phospholipid composition was determined at birth and on day 42 of feeding in 83 term infants fed breast milk, nonsupplemented formula, or 2 different 22:6n-3-supplemented formulas. Relations between 22:6n-3 and 20:4n-6 status at birth and their relative postnatal changes, calculated by the difference between status at the end of the feeding period (6 wk of age) and at birth, were assessed.
Results: Postnatal changes in the plasma and erythrocyte phospholipids 22:6n-3 and 20:4n-6 were negatively related to their respective concentrations at birth (P < 0.01) and the slopes of the regression lines were not significantly affected by the type of milk ingested. Adjusted mean values for phospholipid 22:6n-3 in nonsupplemented-formulafed infants and for 20:4n-6 in formula-fed infants decreased significantly more than they did in the other infant groups (P < 0.02). The status at birth and the type of milk ingested explained 3364% and 747%, respectively, of the variability in postnatal changes.
Conclusions: The status of 22:6n-3 and 20:4n-6 at birth in term infants is one of the major determinants of postnatal changes in these fatty acids. This finding indicates that research is required to characterize environmental, genetic, or both factors, which, in addition to maternal diet, could influence fatty acid status at birth.
Key Words: Arachidonic acid birth status blood phospholipids docosahexaenoic acid postnatal changes breast milk fatty acids term infants France
This article has been cited by other articles:
![]() |
A. R Rudnicka, C. G Owen, M. Richards, M. E. Wadsworth, and D. P Strachan Effect of breastfeeding and sociodemographic factors on visual outcome in childhood and adolescence Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1392 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J T. Brenna, B. Varamini, R. G Jensen, D. A Diersen-Schade, J. A Boettcher, and L. M Arterburn Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1457 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sala-Vila, A. I. Castellote, C. Campoy, M. Rivero, M. Rodriguez-Palmero, and M. C. Lopez-Sabater The Source of Long-Chain PUFA in Formula Supplements Does Not Affect the Fatty Acid Composition of Plasma Lipids in Full-Term Infants J. Nutr., April 1, 2004; 134(4): 868 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Innis and S. L Elias Intakes of essential n-6 and n-3 polyunsaturated fatty acids among pregnant Canadian women Am. J. Clinical Nutrition, February 1, 2003; 77(2): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Massiera, P. Saint-Marc, J. Seydoux, T. Murata, T. Kobayashi, S. Narumiya, P. Guesnet, E.-Z. Amri, R. Negrel, and G. Ailhaud Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J. Lipid Res., February 1, 2003; 44(2): 271 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Decsi, I. Burus, S. Molnar, H. Minda, and V. Veitl Inverse association between trans isomeric and long-chain polyunsaturated fatty acids in cord blood lipids of full-term infants Am. J. Clinical Nutrition, September 1, 2001; 74(3): 364 - 368. [Abstract] [Full Text] |
||||
![]() |
S. L Elias and S. M Innis Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length Am. J. Clinical Nutrition, April 1, 2001; 73(4): 807 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A Tolley and S. E Carlson Considerations of statistical power in infant studies of visual acuity development and docosahexaenoic acid status1 Am. J. Clinical Nutrition, January 1, 2000; 71(1): 1 - 2. [Full Text] [PDF] |
||||
![]() |
S. M Innis Maternal diet, length of gestation, and long-chain polyunsaturated fatty acid status of infants at birth Am. J. Clinical Nutrition, August 1, 1999; 70(2): 181 - 182. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |